News and Media

SOFIX was one of the most successful stock indices in 2021. The indicator outlined a successful trading on the Bulgarian Stock Exchange for both investors and public companies. For the twelve months of last year, the “blue chip” index grew by 42.23% to 635.68 points, showed a study by the newspaper. “Banker”. The main index […]

Tchaikapharma High Quality Medicines obtained marketing authorisations for the Republic of Kosovo for the medicinal products Bilamcar 8 mg/5 mg; 16 mg/5 mg hard capsules and Ceftriaxon-Tchaikapharma 1 g; 2 g powder for solution for injection/infusion. The first deliveries are planned for early 2022.   Thus, the number of registered products of the company in […]

The latest medicinal products to receive Marketing Authorization from the BDA and expand Tchaikapharma’s rich and diverse portfolio are:   – Tamaira Plus 5 mg/5 mg/12.5 mg; 5 mg/5 mg/25 mg; 10 mg/5 mg/25 mg hard capsules (with APIs ramipril, amlodipine and hydrochlorothiazide).   The medicinal product is indicated for the treatment of high blood […]

The first half of this year did not bring much of a stir in stock trading as a consequence of both the development of the pandemic and the slow recovery of the economy.   However, at the end of June this year, the Bulgarian Stock Exchange had a public company with a market capitalization of […]

Tchaikapharma Highquality Medicines, a flagship company on the Bulgarian pharma market, started trading shares on the Bulgarian Stock Exchange (BSE) on 21 May 2015. On today’s date exactly 6 years ago, the initial offering price per share was BGN 3.59, and on 21 May 2021 – BGN 14.10. This represents a growth of 292.757% over […]